AzTrials
AzTrials

Plantar FascitisNCT05462002

Intrinsic Foot Muscle Morphology and Function in Runners With and Without Plantar Fasciitis

An observational study of Plantar Fascitis, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Plantar fasciitis is one of the most common musculoskeletal conditions in distance runners. 44% of patients still had the symptoms after 15 years from the first onset. The chronicity of the condition may lead to significant limitations on daily activities and even cessation of running. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Plantar Fascitis
How many people
64 participants
Where
1 siteHong Kong
Study dates
1 Nov 2021to 1 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Adult

Study population: distance runners who run more than 20km per week for at least 2 years.

Who may be able to join

  • distance runners who run more than 20km per week for at least 2 years. Runners who were between 18 and 60 years of age with symptoms of chronic plantar fasciitis: if they reported tenderness on palpation of the medial calcaneal tuberosity, thickness of plantar fascia >4.0mm at insertion with USG, and exhibited one of the following complaints: 1. plantar heel pain > 1 month; 2 pain on the first step in the morning or after prolonged sitting; 3. pain on prolonged standing; 4 pain when running.

Who cannot join

  • Those who had undergone surgery to the plantar fascia, or had local injection within the last 3 months, or had any coexisting painful musculoskeletal condition of the lower limb, or any neurological or systematic disease were excluded

Trial locations and contacts

1 site in 1 country.

On Yue LAU, PhD candidate contact

(852)64604033

fannielauoy@link.cuhk.edu.hk

Hong Kong1 site, 1 recruiting
  • CUHK-ORT Sports Injury Research Laboratory

    Shatin

    On Yue LAU, Phd candidate, (852) 64604033, fannielauoy@link.cuhk.edu.hk

    Recruiting

Other trials in Hong Kong

About this study

Plantar fasciitis is one of the most common musculoskeletal conditions in distance runners. 44% of patients still had the symptoms after 15 years from the first onset. The chronicity of the condition may lead to significant limitations on daily activities and even cessation of running. In the concept of foot core system, the intrinsic foot muscles work together with plantar fascia to stabilize the foot arches and provide dynamic support to the foot during functional activities. Given that the intrinsic foot muscles also play an important role as a direct sensors of foot deformation, postural control may be compromised during pathological state. Therefore, this study aim to investigate the differences in the muscle thickness and cross-sectional area of intrinsic foot muscles and postural control in runners with and without plantar fasciitis. We hypothesized that runners with plantar fasciitis demonstrate small intrinsic foot muscles sizes and poor postural control when compared with the asymptomatic counterparts.

Read the detailed description

this is a case-control study, using ultrasound imaging (USG) to examine the differences in muscle thickness (MT) and cross-sectional area (CSA) of Abductor Hallucis (AbH), flexor hallucis brevis (FHB), flexor digitorum brevis (FDB), and quadratus plantae (QP), and postural control in runners with and without plantar fasciitis. All participants were recruited through recruitment flyers and word of mouth from local running community. The dependent variables included navicular height using navicular drop test, foot posture using the 6-item Foot Posture Index (FPI-6). The actual status of symptoms was evaluated by visual analog scale (VAS) pain at the first steps in the morning, VAS pain at worst of the day, the Foot Function Index Revised short form (FFI-R S), and the Foot and Ankle Ability Measure (FAAM).

The postural control was assessed by three 10-seconds eyes opened trials and three 10-seconds eyes closed trials single-leg stance recorded on an instrumented force platform . (AMTI. Watertown, MA) at 50 Hz. Center of pressure velocity (cm/s) was calculated for each condition using Balance Clinic software (AMTI. Watertown, MA). In addition, percent modulation was calculated using equation 1 to provide an estimate of a participant's reliance on visual information for the postural control of intrinsic foot muscles.

Equation 1 is as followed.

% modulation= (eyes open velocity-eyes closed velocity)/(eyes open velocity)

Larger negative values represent a greater impairment to postural control when vision is removed and suggest a greater reliance on visual information.

Keywords
intrinsic foot muscle, plantar fasciitis, runners, balance, postural control
Medical subject headings
Fasciitis, Plantar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05462002
Study groupRoleWhat they receive
plantar fasciitis groupDistance runners with plantar fasciitis
asymptomatic control groupDistance runners without plantar fasciitis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle thickness (MT) of Abductor Hallucis (AbH), Flexor Hallucis Brevis (FHB), Flexor Digitorum Brevis (FDB), Quadratus Plantae (QP)

    ultrasound measurement

    Measured: baseline

  2. Cross sectional area (CSA) of Abductor Hallucis (AbH), Flexor Hallucis Brevis (FHB), Flexor Digitorum Brevis (FDB), Quadratus Plantae (QP)

    ultrasound measurement

    Measured: baseline

  3. postural control

    three 10-seconds eyes opened trials and three 10-seconds eyes closed trials single-leg stance recorded on an instrumented force platform. percent modulation was calculated using equation 1 to provide an estimate of a participant's reliance on visual information for the postural control of intrinsic foot muscles.

    Equation 1 is as followed.

    % modulation= (eyes open velocity-eyes closed velocity)/(eyes open velocity)

    Larger negative values represent a greater impairment to postural control when vision is removed and suggest a greater reliance on visual information.

    Measured: baseline

  4. Visual Analog Scale (VAS) pain at first steps in the morning

    measuring 100 mm in length marked from 0 (absence of pain) to 100 mm (worst imaginable pain)

    Measured: baseline

  5. Visual Analog Scale (VAS) worst pain of the day

    measuring 100 mm in length marked from 0 (absence of pain) to 100 mm (worst imaginable pain)

    Measured: baseline

  6. Foot and Ankle Ability Measure (FAAM)

    Higher scores represent higher levels of function, with 100% representing no dysfunction.

    Measured: baseline

  7. Foot Function Index revised short form (FFI-RS)

    grade 1 corresponds to no pain and 4 corresponds to worst pain imaginable. The numerical 5 is not used as a score but is used to indicate that the subscale question is not applicable for the participant. Higher scores represent higher levels of pain, stiffness, difficulty, activity limitation, and psychosocial aspect

    Measured: baseline

Secondary outcomes (2)
  1. Foot posture index (FPI)

    Pronated postures are given a positive value, the higher the value the more pronated.

    Measured: Baseline

  2. Navicular drop

    Supinated foot (<5mm); Neutral foot (5-9mm); pronated foot (>9mm)

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2022
  2. Study start1 Nov 2021
  3. Primary completion1 Nov 2022 (estimated)
  4. Study completion1 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05462002
Sponsor's protocol ID
PF_IFM_Training
Status last verified
Jul 2022
First submitted
8 Jul 2022
Last updated
18 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Plantar Fascitis, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact On Yue LAU, PhD candidate ((852)64604033, fannielauoy@link.cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle thickness (MT) of Abductor Hallucis (AbH), Flexor Hallucis Brevis (FHB), Flexor Digitorum Brevis (FDB), Quadratus Plantae (QP) (time frame: baseline). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in